WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in TXG — 10x Genomics, Inc.

CIK 1632972 PLYMOUTH, MN

Position in TXG

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$6,100,392

+$2,869,462 QoQ

Shares Held

159,113

+4.6% QoQ

Ownership

0.122%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 3% Shared 0% None 97%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $291,122,982 across 58 Medical Devices names. TXG ranks #7 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	1,164,059	$105,626,713
2	MDT	Medtronic plc	921,461	$72,085,894
3	SYK	Stryker Corp	135,035	$42,514,419
4	BSX	Boston Scientific Corp	249,780	$10,660,610
5	EW	Edwards Lifesciences Corp	89,705	$8,114,714
6	ZBH	Zimmer Biomet Holdings, Inc.	74,825	$6,441,684
7	TXG	10x Genomics, Inc. This page	159,113	$6,100,392
8	STE	STERIS plc	28,195	$5,937,021

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,100,392	159,113	+4.6%	Shares	Sole	2026-07-15
2026-03-31	$3,230,930	152,187	+28.2%	Shares	Sole	2026-04-08
2025-12-31	$1,936,094	118,706	+17.6%	Shares	Sole	2026-01-08
2025-09-30	$1,180,023	100,943	+5.1%	Shares	Sole	2025-10-29
2025-06-30	$1,111,691	96,001	+209.1%	Shares	Sole	2025-07-10
2025-03-31	$271,162	31,061	+9.0%	Shares	Sole	2025-04-16
2024-12-31	$409,216	28,497	+19.0%	Shares	Sole	2025-03-17
2024-09-30	$540,836	23,952	+84.0%	Shares	Sole	2024-10-24
2024-06-30	$253,180	13,017	+1.4%	Shares	Sole	2024-07-16
2024-03-31	$481,922	12,841	-37.1%	Shares	Sole	2024-04-15
2023-12-31	$1,141,584	20,400	+0.5%	Shares	Sole	2024-01-30
2023-09-30	$836,921	20,289	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.